by Andrew Vincent | Feb 6, 2026 | Investment News, Press Releases
February 6, 2026 Attomarker launches Acceleration Round to further progress commercial, regulatory and business development milestones Attomarker has today commenced a funding acceleration round to support commercial rollout, regulatory progress, further clinical...